A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Clinical trial NCT04710576 · RECRUITING
Trial details
- NCT number
- NCT04710576
- Sponsor
- Syndax Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-04
- Primary completion
- 2023-04-07
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.